New York State Common Retirement Fund
ALDX icon

New York State Common Retirement Fund’s Aldeyra Therapeutics ALDX Stock Holding History

New York State Common Retirement Fund’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,598
Closed -$16.2K – 3180
2026
Q1 		$16.2K Hold
9,598
– – ﹤0.01% 3040
2025
Q4 		$49.7K Hold
9,598
– – ﹤0.01% 2910
2025
Q3 		$50.1K Hold
9,598
– – ﹤0.01% 2951
2025
Q2 		$36.8K Hold
9,598
– – ﹤0.01% 3020
2025
Q1 		$55.2K Hold
9,598
– – ﹤0.01% 2738
2024
Q4 		$47.9K Hold
9,598
– – ﹤0.01% 2865
2024
Q3 		$51.7K Sell
9,598
-9,000
-48% -$42.8K ﹤0.01% 2855
2024
Q2 		$61.6K Hold
18,598
– – ﹤0.01% 3040
2024
Q1 		$60.8K Hold
18,598
– – ﹤0.01% 2923
2023
Q4 		$65.3K Sell
18,598
-86
-0.5% -$265 ﹤0.01% 2916
2023
Q3 		$125K Buy
18,684
+484
+3% +$3.59K ﹤0.01% 2622
2023
Q2 		$153K Buy
+18,200
New +$179K ﹤0.01% 2618
2022
Q3 		– Sell
-370
Closed -$1K – 3262
2022
Q2 		$1K Sell
370
-31,833
-99% -$109K ﹤0.01% 3310
2022
Q1 		$143K Hold
32,203
– – ﹤0.01% 2935
2021
Q4 		$129K Sell
32,203
-129
-0.4% -$984 ﹤0.01% 3013
2021
Q3 		$284K Sell
32,332
-9,168
-22% -$84.1K ﹤0.01% 2748
2021
Q2 		$470K Buy
+41,500
New +$499K ﹤0.01% 2622
2020
Q2 		– Sell
-17,600
Closed -$43K – 3214
2020
Q1 		$43K Hold
17,600
– – ﹤0.01% 3008
2019
Q4 		$102K Hold
17,600
– – ﹤0.01% 3001
2019
Q3 		$93K Hold
17,600
– – ﹤0.01% 3048
2019
Q2 		$106K Hold
17,600
– – ﹤0.01% 3076
2019
Q1 		$159K Hold
17,600
– – ﹤0.01% 2810
2018
Q4 		$146K Hold
17,600
– – ﹤0.01% 2835
2018
Q3 		$243K Hold
17,600
– – ﹤0.01% 2741
2018
Q2 		$140K Buy
+17,600
New +$140K ﹤0.01% 3014

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

New York State Common Retirement Fund's ALDX Position: Q2 2026 in Review

New York State Common Retirement Fund sold out of Aldeyra Therapeutics (ALDX) in Q2 2026, closing a stake of 9,598 shares — an estimated $16.2K sold.

New York State Common Retirement Fund first reported a position in ALDX in Q2 2018 and held it in 25 quarters. The position peaked at $470K in Q2 2021. 107 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • New York State Common Retirement Fund reported no remaining Aldeyra Therapeutics position as of Q2 2026 after selling out during the quarter.
  • New York State Common Retirement Fund sold 9,598 Aldeyra Therapeutics shares in Q2 2026, an estimated $16.2K.
  • New York State Common Retirement Fund first reported a position in Aldeyra Therapeutics in Q2 2018 and held it in 25 quarters.
  • New York State Common Retirement Fund's Aldeyra Therapeutics position peaked at $470K in Q2 2021.
  • 107 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.